Wall Street analyst estimates for Keurig Dr Pepper Inc. (KDP): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Keurig Dr Pepper Inc. is a prominent beverage firm with operations spanning both the United States and global markets. The company structures its business across four primary divisions: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages.
Consensus price target
$38.86 (+12 % vs price $34.74)
between $37.00 and $42.00 · 4 targets published in the last quarter
Closing price, Nov 3
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $26.3B | $26.2B – $26.4B | $2.29 | 11 |
| 2027E | $29.9B | $29.6B – $30.2B | $2.52 | 11 |
| 2028E | $30.9B | $30.3B – $31.5B | $2.72 | 7 |
Figures in USD · consensus as of November 2, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 18 |
| Hold | 11 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 29 |
| Avg rating (−2 sell to +2 buy) | 0.62 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-03 | $0.62 | ||
| 2026-08-06 | $0.57 | $0.54 | +6.1% |
| 2026-04-23 | $0.39 | $0.37 | +4.7% |
| 2026-02-24 | $0.60 | $0.59 | +1.9% |
| 2025-10-27 | $0.54 | $0.54 | +0.6% |
| 2025-07-24 | $0.49 | $0.49 | +1.0% |
| 2025-04-24 | $0.42 | $0.38 | +9.8% |
| 2025-02-25 | $0.58 | $0.57 | +1.6% |
Valuation Ratios
| P/E Ratio | 34.95 |
| Price / Book | 1.86 |
| Dividend Yield | 2.65% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.44B | $6.69B | $7.44B | $11.12B | $11.62B | $12.68B | $14.06B | $14.81B | $15.35B | $16.60B |
| Cost of Revenue | $2.58B | $2.69B | $3.56B | $4.78B | $5.13B | $5.71B | $6.73B | $6.73B | $6.82B | $7.60B |
| Gross Profit | $3.86B | $4.00B | $3.88B | $6.34B | $6.49B | $6.98B | $7.32B | $8.08B | $8.53B | $9.00B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $2.33B | $2.56B | $2.63B | $3.96B | $3.98B | $4.15B | $4.64B | $4.91B | $5.01B | $5.35B |
| Operating Expenses | $2.42B | $2.61B | $2.65B | $3.96B | $4.01B | $4.08B | $4.54B | $4.89B | $5.22B | $5.35B |
| Operating Income | $1.43B | $1.39B | $1.24B | $2.38B | $2.48B | $2.89B | $2.78B | $3.19B | $3.31B | $3.65B |
| EBITDA | $1.65B | $1.57B | $1.68B | $3.01B | $3.01B | $4.01B | $3.12B | $3.97B | $3.38B | $4.19B |
| Interest Expense | $140.0M | $168.0M | $446.0M | $647.0M | $597.0M | $525.0M | $468.0M | $596.0M | $684.0M | $754.0M |
| Pre-tax Income | $1.28B | $1.17B | $791.0M | $1.69B | $1.75B | $2.80B | $1.72B | $2.76B | $1.91B | $2.69B |
| Income Tax | $434.0M | $95.0M | $202.0M | $440.0M | $428.0M | $653.0M | $284.0M | $576.0M | $473.0M | $608.0M |
| Net Income | $847.0M | $1.08B | $586.0M | $1.25B | $1.32B | $2.15B | $1.44B | $2.18B | $1.44B | $2.08B |
| EPS | $4.57 | $5.91 | $0.54 | $0.89 | $0.94 | $1.52 | $1.01 | $1.56 | $1.06 | $1.53 |
| EPS (Diluted) | $4.54 | $5.89 | $0.53 | $0.88 | $0.93 | $1.50 | $1.01 | $1.55 | $1.05 | $1.53 |
| Shares Outstanding (Diluted) | 186.6 M | 182.8 M | 1,097.6 M | 1,419.1 M | 1,422.1 M | 1,427.9 M | 1,428.5 M | 1,408.4 M | 1,368.3 M | 1,362.8 M |
Price
| Price | $34.74 (closing price, November 3, 2026) |
| Market Cap | $47.3B |
| Exchange | NASDAQ |
| Country | US |
Related companies: PEP · MNST · CCEP · COKE · CELH · FIZZ · KO · KOF
Explore sector: Consumer Defensive · Beverages - Non-Alcoholic
More sections of KDP: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks